Annual Biomarkers Congress

Osaka | Japan   September 20-21, 2018

Theme: Biomarkers: a new era of detection and clinical exploration

Meetings International proudly announces the Annual Biomarkers Congress” which will be held during September 20-21, 2018 at Osaka, Japan. Biomarkers Congress 2018 aims to assemble experts from pharma and biopharma, eminent scientists, research scholars, educationists, professors to express their views on the latest update of Biomarkers.

Meetings International provides an international platform of bioinformatics, biotechnologists, and genomics, medical healthcare professionals the theme of the Annual Biomarkers Congress" Biomarkers: a new era of detection and clinical exploration ", will be focused to refer to a substance whose detection indicates the presence of a living organism. Meetings International (Meetings Int.) is a worldwide pioneer in delivering top notch meetings, gatherings, workshops and symposia in every significant field of science, innovation and medication. Since its beginning, Meetings Int. has been related with national and universal affiliations, partnerships, devoted to have world class meetings and occasions. Meetings Int. underpins expansive degree research and associate audit at a wide scope of authorities around the globe. The key vital goal of Meetings Int. is to impart science and medicinal research amongst the academic/scholarly community, and industry.

Biomarkers, in the hands of the clinical inspector, offers a powerful and effective approach to understanding the opportunity of diseases with distinct applications in analytic epidemiology, biomarkers and clinical research in disease prevention, detection and disease management. Biomarkers have the possible supplementary to find each susceptible to particular diseases. This conference is a platform that brings and shares collective ideas, knowledge and research survey in biomarkers study. In the recent years, the statistics about cancer biomarkers has expanded a massive potential for upgrade the administration of cancer patients by boost the precision of diagnosis and efficacy of treatment. Recent technological improvement has a license the investigation of many viable biomarkers and recommences interest in advancing new biomarkers. All such developments can be exhibits in this biomarker congress.

World Biomarkers 2018 conference will be organized by Meetings International which is comprised of 3000+ international Events with over 2000+ Conferences, 1200+ Symposiums and Workshops on multiple fields of clinical, medical, Pharmaceutical, Engineering, Science, Technology, and Business.

Why To Attend?

This is the best opportunity to reach the largest mass of participants from the Biomarkers and its associated areas. Conduct presentations, distribute statistics, meet with current and potential scientists, construct a dashing with new Development of Biomarkers, and receive name identification at this 2-day event. World-renowned speakers, the most recent techniques, evolution, and the recent updates in Biomarkers are hallmarks of this conference.

Target Audience: 

·         Biomarker Research Students and Scientists

·         Biomarker Researchers

·         Cancer and other Diseases Researchers

·         Medical Colleges & Pharmacology Professionals

·         Biomarker Associations and Societies

·          Bio pharmacists, Biochemist, and Biotech Professionals

·         Manufacturing Biomarkers Instruments Companies

·         Research and Diagnostic Laboratories and Companies

·         Data Management Companies

·         Pharmaceutical Companies

·         Business Entrepreneurs

For more details, please visit: https://www.meetingsint.com/conferences/biomarkers

Session 1: Biomarker

biomarker or biological markers are naturally occurring molecule, gene, or characteristic by which a particular pathophysiological a natural process, disease, etc. can be identified or examined. For some biological state or condition, on biomarkers refer as a measurable indicator. In cell biology, a biomarker is a molecule that allows the observation and separation of a distinct cell, In genetics, a biomarker is a DNA sequence that causes disease and biomarkers are used to specify an exposure to or the impact of xenobiotic which are present in the environment and in organisms, in field of geology and astrobiology biomarkers are also used and also known as bio signatures.

Related Biomarker Conferences and Societies: 13th Annual Biomarkers Congress, February 15-16, 2018, Manchester, UK; 11th Biomarker Summit, March 27-28, 2018, San Diego, Canada; Biomarkers and Immuno-Oncology World Congress 2018, June 11-13, 2018, Boston, MA, US; 4th Biomarker Meeting: Personalized Reproductive Medicine, April 12-13, 2018, Valencia, Spain; 2nd  World Congress on Clinical Research & Biomarkers, September 17-18, 2018, Toronto, Canada; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, UK; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, USA; Biochemical Society, UK; Fatebenefratelli Association for Research, Italy.

Session 2: Clinical Biomarker

A Biomarker is used as an indicator of the particular state of disease or physical state of an organization. Radium chloride is used in isotopic labeling to evaluate perfusion of the heart muscle. Biomarkers can be specific cells, molecular genes, gene products, enzymes or hormones. Body temperature act as a biomarker to detect the risk of heart stroke. Cholesterol values are also biomarkers to indicate coronary and vascular disease. For cholesterol serum LDL is used as a biomarker. MPs act as tumor markers for cancer. Biomarkers help in diagnosis disease prevention and therapeutic regimes for a particular cancer type and its recurrence.

Related Biomarker Conferences and Societies: 2nd World Congress on Clinical Research & Biomarkers, September 17-18, 2018, Toronto, Canada;  Innovation and Biomarkers in Cancer Drug Development (IBCD), November 29-30, 2018, Brussels, Belgium; Biomarkers and Immuno-Oncology World Congress 2018, June 11-13, 2018, Boston, MA, US; 4th Biomarker Meeting: Personalized Reproductive Medicine, April 12-13, 2018, Valencia, Spain; 2nd World Congress on Clinical Research & Biomarkers, September 17-18, 2018, Toronto, Canada; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, UK; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, USA; Biochemical Society, UK; Fatebenefratelli Association for Research, Italy.

Session 3: Biomarker Sciences

Biomarkers used in translational research, addressing the entire spectrum from discovery to evaluation and commercialization. Good Biomarker Sciences access to different lines of biomarker platforms that can be used to dissect the precise action of drugs or monitor patient’s health. From reviewing existing scientific data to full study design and optimization, throughout in-depth interpretation and recommendations, clinical trials.

Related Biomarker Conferences and Societies: 4th Biomarker Meeting: Personalized Reproductive Medicine, April 12-13, 2018, Valencia, Spain; 11th Biomarker Summit, March 27-28, 2018, San Diego, Canada; Biomarkers and Immuno-Oncology World Congress 2018, June 11-13, 2018, Boston, MA, US; Circulating Biomarkers World Congress 2018, March 28-29,2018, Boston, USA; 2nd World Congress on Clinical Research & Biomarkers, September 17-18, 2018, Toronto, Canada; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, UK; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, USA; Biochemical Society, UK; Fatebenefratelli Association for Research, Italy.

Session 4: Biomarker Discovery          

Biomarkers inquire about takes a continuity that starts with exposure and extends through acceptance to the possible performance of biomarkers in a clinical surrounding. Biomarker disclosure needs high validity identifiable proof of biomarker applicants with simultaneous calculate data to display which proteins are altering to an authentic important degree in light of contamination. Biomarker competitors distinguished in exposure should be approved utilizing bigger example sets covering an expansive segment of patient companions.

Related Biomarker Conferences and Societies: Molecular Biomarker Conference, November 29-30, 2018, Dublin, Ireland; 8th Annual Conference on clinical research and Biomarkers, July 19-20, 2018, Prague, Czech Republic; Circulating Biomarkers World Congress 2018, March 28-29,2018, Boston, USA; Innovation and Biomarkers in Cancer Drug Development (IBCD), November 29-30, 2018, Brussels, Belgium; International Conference on Biomarkers and Cancer Targets 2018, July 16-17,2018, Dubai, UAE; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; Federation of European Neuroscience Societies, Europe; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, England; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, Chicago; Biochemical Society, London; Fatebenefratelli Association for Research, Italy.

Session 5: Biomarker operation

A biomarker plays a vital role in the field of medicines, cell biology, geology, and astrobiology &ecotoxicology. In medicine, a biomarker acts as a traceable substance to examine the function of organs e.g. rubidium chloride is used as a radioactive isotope to measure perfusion of the muscle of the heart. It also detects the presence of an antibody that indicates infection. Biomarkers based on electrical activity of the brain are used in electroencephalography. Using magnetically resonance imaging or saliva testing volumetric measure of brain regions is detected. Prostate Specific Antigen (PSA) can be measured as a proxy of prostate size with rapid changes potentially indicating cancer.

Related Biomarker Conferences and Societies: Innovation and Biomarkers in Cancer Drug Development (IBCD), November 29-30, 2018, Brussels, Belgium; 8th Annual Conference on clinical research and Biomarkers, July 19-20, 2018, Prague, Czech Republic; Circulating Biomarkers World Congress 2018, March 28-29,2018, Boston, USA;  Molecular Biomarker Conference, November 29-30, 2018, Dublin, Ireland; International Conference on Biomarkers and Cancer Targets 2018, July 16-17,2018, Dubai, UAE; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; Federation of European Neuroscience Societies, Europe; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, England; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, Chicago; Biochemical Society, London; Fatebenefratelli Association for Research, Italy.

Session 6: Translation research/sciences

The specialty of biomarker invention has displayed a great surge of interest in recent years. We can use biomarkers for many reasons including diagnosis, prognosis, and choosing suitable patient treatment, and can give data on disease mechanism. Translation of such markers to clinical testing include steps for their discovery and characterization, assay development, and finally, an application using automated podium working in clinical laboratories. With a target on protein-based biomarkers and clinical immunoassays, the three parts are a debate in greater point. The currently used technologies in the clinical laboratory are described, including ascribe of in.

Related Biomarker Conferences and Societies: Molecular Biomarker Conference, November 29-30, 2018, Dublin, Ireland; 8th Annual Conference on clinical research and Biomarkers, July 19-20, 2018, Prague, Czech Republic; Circulating Biomarkers World Congress 2018, March 28-29,2018, Boston, USA; Innovation and Biomarkers in Cancer Drug Development (IBCD), November 29-30, 2018, Brussels, Belgium; International Conference on Biomarkers and Cancer Targets 2018, July 16-17,2018, Dubai, UAE; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; Federation of European Neuroscience Societies, Europe; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, England; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, Chicago; Biochemical Society, London; Fatebenefratelli Association for Research, Italy.

Session 7: Companion Diagnostics

A medical tool, which is often an in vitro tool and which provide data need a key for the safe and applicable use of a individual drug management or biological product is called a companion diagnostic. These tools help to decide whether a particular remedial product’s benefits to a patient will be of more help that can conceal any viable serious side effects or risks to treat a patient. These biomarkers congresses invite the latest technologies and techniques to be brought into the light. A partnership between cancer pharmaceutics and diagnostics is a sensitive relation as there is often accident due to lack of knowledge of requirements and feasibilities. The strategies for Rx-Dx partnerships provide a good platform for sharing the knowledge. Development of in-vitro companion diagnostic devices and their commercialization is a rapidly budding area. These diagnostics are useful in the study of surgical oncology.

Related Biomarker Conferences and Societies: 13th Annual Biomarkers Congress, February 15-16, 2018, Manchester, UK; 11th Biomarker Summit, March 27-28, 2018, San Diego, Canada; Biomarkers and Immuno-Oncology World Congress 2018, June 11-13, 2018, Boston, MA, US; 4th Biomarker Meeting: Personalized Reproductive Medicine, April 12-13, 2018, Valencia, Spain; 2nd World Congress on Clinical Research & Biomarkers, September 17-18, 2018, Toronto, Canada; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, UK; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, USA; Biochemical Society, UK; Fatebenefratelli Association for Research, Italy.

Session 8: Precision medicines

Precision medicine depends on endorse biomarkers with which to satisfactory categorize victim by their predictable disease risk, prediction and/or response to treatment. Although inexpensive 'comics'-based technology has allowed faster identification of assumed biomarkers, the validation of biomarkers is still defeated by low mathematical power and poor productivity of results. This Review summarizes the successes and dare of using various types of the molecule as biomarkers, using lung cancer as a key representative example. Efforts at the national level of several countries to bind molecular assessment of specimen to patient data via electronic medical evidence are the future of precision medicine research.

Related Biomarker Conferences and Societies: 4th Biomarker Meeting: Personalized Reproductive Medicine, April 12-13, 2018, Valencia, Spain; 8th Annual Conference on clinical research and Biomarkers, July 19-20, 2018, Prague, Czech Republic; Circulating Biomarkers World Congress 2018, March 28-29,2018, Boston, USA; Innovation and Biomarkers in Cancer Drug Development (IBCD), November 29-30, 2018, Brussels, Belgium; International Conference on Biomarkers and Cancer Targets 2018, July 16-17,2018, Dubai, UAE; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; Federation of European Neuroscience Societies, Europe; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, England; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, Chicago; Biochemical Society, London; Fatebenefratelli Association for Research, Italy.

Session 9: Personalized Medicine

Personalized medicine is a new field of research and evidence-based literature is required for integrating into healthcare delivery. Personalized medicine is known for its use of genomic information along with the family and lifestyle for a health management .accurate prediction made about a person susceptibility to developing the disease and course of the disease and response to the treatment.

Related Biomarker Conferences and Societies: Biomarkers and Immuno-Oncology World Congress 2018, June 11-13, 2018, Boston, MA, US; 11th Biomarker Summit, March 27-28, 2018, San Diego, Canada; 13th Annual Biomarkers Congress, February 15-16, 2018, Manchester, UK; 4th Biomarker Meeting: Personalized Reproductive Medicine, April 12-13, 2018, Valencia, Spain; 2nd World Congress on Clinical Research & Biomarkers, September 17-18, 2018, Toronto, Canada; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, UK; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, USA; Biochemical Society, UK; Fatebenefratelli Association for Research, Italy.

Session 10: Biomarker Research

Biomarkers are key molecular or cellular events which link a specific environmental exposure to a health outcome. A biomarker is an appropriate tool which can be reasonably calculated and can act as a measure for physiological as well as pathological improvement to any therapeutic involvement. Classical biomarkers discover quantitative alteration in blood pressure; blood lactate levels post exercises, and blood glucose in diabetes mellitus. A biomarker, or bioindicator, for the most part, alludes to a quantifiable pointer of some organic state or condition. The term is additionally infrequently used to allude to a substance the nearness of which demonstrates the presence of a living being. Environmental Assessment also carried out in the natural or synthetic form as bio-monitoring. Encourage, life structures, life events for Interim analysis. Biomarkers are regularly measured and assessed to look at ordinary natural procedures, pathogenic procedures, or pharmacologic reactions to a restorative mediation.

Related Biomarker Conferences and Societies: Molecular Biomarker Conference, November 29-30, 2018, Dublin, Ireland; 8th Annual Conference on clinical research and Biomarkers, July 19-20, 2018, Prague, Czech Republic; Circulating Biomarkers World Congress 2018, March 28-29,2018, Boston, USA; Innovation and Biomarkers in Cancer Drug Development (IBCD), November 29-30, 2018, Brussels, Belgium; International Conference on Biomarkers and Cancer Targets 2018, July 16-17,2018, Dubai, UAE; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; Federation of European Neuroscience Societies, Europe; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, England; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, Chicago; Biochemical Society, London; Fatebenefratelli Association for Research, Italy.

Session 11: Biomarker in oncology

The indicative process of the presence of cancer in the body is referred as cancer biomarkers. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. There are different of cancer where biomarkers have it application such as lung, Melanoma, breast, Colorectal, Pancreas and many more. Biochemically, cancer biomarkers can be DNA (germline or somatic), RNA, proteins, peptides, hormones, metabolites, and even biological processes such as apoptosis, angiogenesis or proliferation. There are three major types of cancer biomarkers based on their clinical use: prognostic, predictive, and pharmacodynamics markers.

Related Biomarker Conferences and Societies: 13th Annual Biomarkers Congress, February15-16, 2018, Manchester, UK; 11th Biomarker Summit, March 27-28, 2018, San Diego, Canada; Biomarkers and Immuno-Oncology World Congress 2018, June 11-13, 2018, Boston, MA, US; 4th Biomarker Meeting: Personalized Reproductive Medicine, April 12-13 2018, Valencia, Spain; 2nd World Congress on Clinical Research & Biomarkers, September 17-18, 2018, Toronto, Canada; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; Federation of European Neuroscience Societies, Europe; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, England; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, Chicago; Biochemical Society, London; Fatebenefratelli Association for Research, Italy.

Session 12: Immunology biomarker

Study of immune system biomarkers is called immunology biomarkers. Biomarkers discovery and discussed the framework for applying these concepts in the study of the immune system and its effects on the disease – cancer, infection, allergy, immunodeficiency, and autoimmunity. In biomarkers discovery, the immune system plays an important role since it interacts with all other systems in the human body and immune biomarkers are relevant for a large number of diseases.

Related Biomarker Conferences and Societies: 7th World Biochemistry and Biomarkers Conference and Expo, November 2-4, 2018, Copenhagen, Denmark; 12th International Conference and Expo on Proteomics and Molecular Medicine, November 26-28, 2018, Dublin, Ireland; Biomarkers and Immuno-Oncology World Congress 2018, June 11-13, 2018, Boston, MA, US; 4th Biomarker Meeting: Personalized Reproductive Medicine, April 12-13, 2018, Valencia, Spain; 2nd World Congress on Clinical Research & Biomarkers, September 17-18, 2018, Toronto, Canada; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; Federation of European Neuroscience Societies, Europe; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, England; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, Chicago; Biochemical Society, London; Fatebenefratelli Association for Research, Italy.

Session13: Molecular Biomarker

Molecular Biomarkers is the biomarker that is in molecular form. These molecular biomarkers used in the processes of disease diagnosis, disease prognosis, prediction and calculation of the therapy response and the evaluation of the biomarkers. The molecular biomarkers are developed and validated to use it in drug development processes. Protein biomarkersnucleic acid biomarkers, small molecule biomarkers, lipid biomarkers and micro RNA biomarkers are the example of biomarkers. The atomic biomarkers are only being created and approved to be utilized as a part of medical improvement and used to bolster endorsement of medication items.

Related Biomarker Conferences and Societies: Innovation and Biomarkers in Cancer Drug Development (IBCD), November 29-30, 2018, Brussels, Belgium;  Molecular Biomarker Conference, November 29-30, 2018, Dublin, Ireland; Biomarkers and Immuno-Oncology World Congress 2018, June 11-13, 2018, Boston, MA, US; 13th Annual Biomarkers Congress, February15-16, 2018, Manchester, UK; 2nd World Congress on Clinical Research & Biomarkers, September 17-18, 2018, Toronto, Canada; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; Federation of European Neuroscience Societies, Europe; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, England; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, Chicago; Biochemical Society, London; Fatebenefratelli Association for Research, Italy.

Session 14: Biomarker and Drug Discovery

The part of Biomarkers in medication declaration and advancement is to understand the physiopathology of a disorder. Biomarkers can be a clinical apparatus for medication revelation and upgrade by acceptability and security to the correct patient. Biomarkers can be utilized as a part of knowledge about the instrument of medication.

Related Biomarker Conferences and Societies: Molecular Biomarker Conference, November 29-30, 2018, Dublin, Ireland; 8th Annual Conference on clinical research and Biomarkers, July 19-20, 2018, Prague, Czech Republic; Circulating Biomarkers World Congress 2018, March 28-29,2018, Boston, USA; Innovation and Biomarkers in Cancer Drug Development (IBCD), November 29-30, 2018, Brussels, Belgium; International Conference on Biomarkers and Cancer Targets 2018, July 16-17,2018, Dubai, UAE; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; Federation of European Neuroscience Societies, Europe; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, England; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, Chicago; Biochemical Society, London; Fatebenefratelli Association for Research, Italy.

Session 15: Case Reports

In the clinical trials process biomarkers are intended to replace surrogate endpoints. Surrogate markers are used to conduct the clinical trials and gather a no. of endpoints. The endpoint is impractical when the primary endpoint is undesired or the event number is small. The diagnostic and clinical development process biomarker helps much. Biomarkers case study plays an important role in finding a new treatment for the patients who need a new drug for various clinical practice.

Related Biomarker Conferences and Societies: 13th Annual Biomarkers Congress, February 15-16, 2018, Manchester, UK; 11th Biomarker Summit, March 27-28, 2018, San Diego, Canada; Biomarkers and Immuno-Oncology World Congress 2018, June 11-13, 2018, Boston, MA, US; 4th Biomarker Meeting: Personalized Reproductive Medicine, April 12-13, 2018, Valencia, Spain; 2nd World Congress on Clinical Research & Biomarkers, September 17-18, 2018, Toronto, Canada; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; Federation of European Neuroscience Societies, Europe; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, England; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, Chicago; Biochemical Society, London; Fatebenefratelli Association for Research, Italy.

Session 16:Biomarkers & Next-Generation Sequencing

There is a revolution in the study of genomics and molecular biology DNA and RNA sequencing is rapid than the past strategy due to the Next-generation sequencing. Genetic-based biomarkers are the biomarkers involved in the process of representing gene and gene products. In the discovery of biomarkers, the genome sequencing using next-generation helps a lot.

Related Biomarker Conferences and Societies: Innovation and Biomarkers in Cancer Drug Development (IBCD), November 29-30, 2018, Brussels, Belgium;  Molecular Biomarker Conference, November 29-30, 2018, Dublin, Ireland; Biomarkers and Immuno-Oncology World Congress 2018, June 11-13, 2018, Boston, MA, US; 13th Annual Biomarkers Congress, February 15-16, 2018, Manchester, UK; 2nd World Congress on Clinical Research & Biomarkers, September 17-18, 2018, Toronto, Canada; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; Federation of European Neuroscience Societies, Europe; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, England; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, Chicago; Biochemical Society, London; Fatebenefratelli Association for Research, Italy.

Session17: Biomarkers identification techniques

Those putative biomarkers for Disease diagnosis and prognosis the complexity of structure and function of protein biomarkers and lack of high sensitivity, specificity, and reproducibility. The Food and drug administration has approved few biomarkers due to its advanced technology. The practical application of each protein separation or identification technique is analyzed using specific examples, Including four major application of immunology as ELISA, FACS, Western Blot and Immunoprecipitation. Mass spectrometers are unique which can directly analyze any biological molecule likely to be influenced by ionization. The biological studies of human metabolites and proteins using recent mass spectrometry technology (metabolomics and proteomics, respectively) have been ongoing for over a decade.

Related Biomarker Conferences and Societies: 7th  World Biochemistry and Biomarkers Conference and Expo, November 2-4, 2018, Copenhagen, Denmark; 12th International Conference and Expo on Proteomics and Molecular Medicine, November 26-28, 2018, Dublin, Ireland; Biomarkers and Immuno-Oncology World Congress 2018, June 11-13, 2018, Boston, MA, US; 4th Biomarker Meeting: Personalized Reproductive Medicine, April12-13, 2018, Valencia, Spain; 2nd  World Congress on Clinical Research & Biomarkers, September 17-18, 2018, Toronto, Canada; International Society for Bayesian Analysis (ISBA), USA; American Society of Clinical Oncology, America; Federation of European Neuroscience Societies, Europe; American Association for Cancer Research, America; ALS Association, America; German Society for Oncological Pharmacy, Germany; The British Association for Cancer Research, England; The International Society Of Oncology and Biomarkers, Spain; Union of International Associations, Belgium; World Molecular Imaging Society, Canada; Clinical Research Association of Canada, Canada; Osteoarthritis Research Society International, USA; Alzheimer's Association, Chicago; Biochemical Society, London; Fatebenefratelli Association for Research, Italy.

 

 

Annual biomarker conference is the best forecast conference. It is the best way to integrate with industry squint and discover knowledge and resources. This is the best platform to achieve the largest gathering of participants from the biomarkers and genomics community. This is the best platform for them who are well reputed in this field like professors, oncologists, scientists, students, research scholars. To enhance the biomarkers market this global event is perfect for new biomarkers in different applications.

Meetings International warmly invites all the renowned character, Reputed Scientists and Speakers, Industry Professionals, Healthcare and educational Professionals from the Healthcare and Oncology field to share their ideas and methodologies in this global event. This will bring excellent result. It is open to all types of research methodologies both from academic and industry

Description

Biomarkers Congress 2018 aims to provide a unique scientific and technical platform to share the research experiences among the best-available experts and professionals from all over the world. It will include keynote speakers, session speakers, poster presenters who will be presenting their innovative research on the topics such as Biomarker, Biomarkers in medicines, Biomarkers in cancer detection, Biomarkers in drug development, Biomarkers in toxicology, Development of biomarkers, genomics biomarkers, protein biomarkers, diagnostic biomarkers. The important structures of this conference are an opening session; topical sessions with keynote addresses and oral contributions, symposium, poster presentations well-organized workshops and world-class exhibits, panel discussions, interactive sessions, panel discussions, collaborative research opportunities.

The biomarkers market is forecast to reach USD 53.34 Billion by 2021 from USD 27.95 Billion in 2016, developing at a CAGR of 13.8% during the forecast period (2016–2021). Disease diagnostic application remains the key area of application that is expected to reach 6.1 $billion in 2020.But, application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly. Molecular diagnostics is expected to grow at a CAGR of 17.6% from 2013 to 2020.

Scope

Market by technologies, market by services, and market by diseases are the three categories of the report section in a market of Global Diagnostic Biomarker. These markets are expected to display raised growth in future as biomarkers are providing diagnostic service for complicated disease. As it is non-invasive mechanism it prompts the use of biomarkers than conventional diagnostic applications. This report focuses on key factors impacting the diagnostic biomarker market used in risk analysis, disease diagnosis, molecular diagnostics, drug discovery and development, forensic applications, drug formulation and others. Diagnostic biomarker and its applications in emerging sections of omics, imaging technologies, customized medicine, and bioinformatics are all examined in detail.

Asia-Pacific biomarkers market is separated based on the product, category, application, and disease symptom. Based on product, the market is further sub-separated as consumables, software, and services. Based on the type, the market is separated as welfare biomarkers, efficacy biomarkers, and validation biomarkers. Biomarkers application is again separated as diagnostics developments, drug discovery & developments, customized medicine, and disease risk analysis. Based on disease symptom, the market is separated as cancer, cardiovascular, neurological, and immunological disorders.

Global Expert Meetings Annual Biomarkers Congress will be organized during September 20-21, 20182018 in Osaka, Japan. Biomarkers Congress 2018 aims to gather eminent scientists, research scholars, and educationists and professionals to express their views on the latest technologies, trends in biomarkers. It centralizes on addressing the constant effort being made by scientist and scholars to improve the existing and inventing novel technologies for future.

Conference Highlights:

·         Biomarker

·         Clinical Biomarker

·         Biomarker Sciences

·         Biomarker Discovery

·         Biomarker Operations

·         Translational research/Sciences

·         Companion Diagnostics

·         Precision medicine

·         Personalized medicine

·         Biomarker research

·         Biological Sciences

·         Biomarkers in oncology

·         Immunology Biomarkers

·         Molecular Biomarkers

·         Biomarkers and Drug Discovery

·         Case Reports

·         Biomarkers and Next-Generation Sequencing

·         Biomarker Identification Technique

Associations & Societies Related to Biomarkers:

·         The Academy of Medical Sciences

·         Arthritis Research UK

·         Biotechnology and Biology Research Sciences Council

·         The Arthritis Foundation

·         The Canon Foundation

·         Baxter International Foundation, USA

·         Sumitomo Foundation

·         National Science Foundation

Global Universities Related to Biomarkers:

·         Charles University, Czech Republic

·         University of Illinois at Chicago, USA

·         Chongqing University, China

·         The University of Texas, USA

·         University of Nottingham, UK

·         Institute of Life Sciences (An Autonomous Institute under Department of Biotechnology, Govt. of India), India

·         King Abdulaziz University, Saudi Arabia

·         Austrian Institute of Technology, GmbH, Austria

·         Georg August University Göttingen, Germany

·         University of Toronto, Canada

·         I.M.Sechenov First Moscow State Medical University, Russia

·         University of São Paulo Medical School, Brazil

·         University of Milan, Italy

·         Mahidol University, Thailand

·         Università degli Studi di Modena e Reggio Emilia, Italia

·         Monash University, Sri Lanka

·         Kermanshah University of Medical Sciences, Iran

·         National & Kapodistrian University of Athens (NKUA), Greece

·         Marmara University, Turkey

Major companies:

·         Abbott Laboratories, Inc. (USA)

·         Novartis (USA)

·         Abaxis Inc. (USA)

·         Hitachi High-Technologies Corp.

·         Medica Corp. (USA)

·         Mindray Medical International Ltd. (China)

·         Thermo Fisher Scientific Inc. (USA)

·         Pfizer (USA)

·         Merck (USA)

·         Novo Nordisk (Denmark)

·         GlaxoSmithKline (UK)

·         Bristol-Myers Squibb (USA)

·         Vertex Pharmaceuticals Inc., (USA)

·         Biocrates (Austria)

·         Gilead Sciences (USA)

·         Biogen Idec, (USA)

·         Celgene, USA

·         Shire Pharmaceuticals (Ireland)

·         Genzyme Corp. (USA)

·         Human Genome Sciences Inc. (UK)

Global funding Agencies:

·         The Academy of Medical Sciences

·         Biotechnology and Biology Research Sciences Council

·         Arthritis Research UK

·         The Arthritis Foundation 

·         The Canon Foundation

·         Baxter International Foundation, USA

·         National Science Foundation

·         Sumitomo Foundation

·         South African Medical Research Council

 

  • Biomarker
  • Clinical Biomarker
  • Biomarker Sciences
  • Biomarker Discovery
  • Biomarker Operations
  • Translational research/Sciences
  • Companion Diagnostics
  • Precision medicine
  • Personalised medicine
  • Biomarker research
  • Biological Sciences
  • Biomarkers in Oncology
  • Immunology Biomarkers
  • Molecular Biomarkers
  • Biomarkers and Drug Discovery
  • Case Reports
  • Biomarkers and Next-Generation Sequencing
  • Biomarker Identification Technique

13 Organizing Committee Members

3 Renowned Speakers

Nancy Lan Guo

West Virginia University, USA
USA

Thomas Bayne

Microbiome Labs, USA
USA

Yoshinori Murakami

University of Tokyo, Japan
Japan

Media Partners & Collaborations

  • Media Partner

  • Media Partner

  • Media Partner

  • Media Partner

  • Media Partner

  • Collaboration